Expanding at a robust CAGR of 9.0%, the global mammalian derived proteins market is projected to grow from USD 588.9 million in 2021 to USD 1.5 billion by 2032.
The mammalian derived proteins market is experiencing significant growth, driven by the increasing prevalence of cancer, fertility-related conditions, and the rising adoption of hormonal therapies. These factors are expected to fuel demand for mammalian derived proteins, which are considered the gold standard in therapeutic applications due to their superior binding activity.
Mammalian derived proteins are essential in the production of monoclonal antibodies (MABs), clotting factors, and hormones, making them indispensable in the biotechnology and pharmaceutical industries. Their use is driven by their high potential for producing large, complex protein molecules that are vital for treating a wide range of diseases and disorders.
Mammalian cell cultures, particularly mouse myeloma and Chinese hamster ovary (CHO) cell systems, are widely employed to synthesize these proteins due to their robust ability to tolerate environmental changes and their efficiency in protein production. These cell cultures play a crucial role in advancing the development of biotherapeutics, positioning mammalian derived proteins at the forefront of medical innovation.
As the global demand for these proteins continues to rise, the market is expected to see accelerated growth, providing promising opportunities for stakeholders in the biopharmaceutical and healthcare sectors.
Key Market Drivers:
- Rising Prevalence of Cancer and Fertility Conditions: As cancer and fertility-related issues become more common, the need for targeted treatments and therapies, including those utilizing mammalian derived proteins, is increasing.
- Growing Adoption of Hormonal Therapies: Hormonal therapies are gaining traction, further enhancing the demand for mammalian derived proteins, particularly in therapeutic applications for conditions like hormone imbalances and reproductive health.
The growth of the mammalian derived proteins market underscores the increasing reliance on advanced biotechnological solutions to address some of the world’s most pressing health challenges. With a strong projected growth rate, the sector is poised to continue evolving, playing an essential role in the future of medicine and therapeutic development.
Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report!
The Mammalian Derived Proteins Market is experiencing significant growth, driven by increasing demand across various industries, such as biotechnology, pharmaceuticals, and research. Regions with strong growth potential in this market include:
- North America:
- United States is the dominant player in the global mammalian-derived proteins market. The region benefits from a highly advanced healthcare system, a robust pharmaceutical and biotechnology sector, and significant investments in research and development (R&D).
- The increasing use of mammalian cell culture-based processes in the development of biologics, vaccines, and therapeutics is a major growth driver.
- With a well-established market for biopharmaceuticals, along with strong regulatory frameworks and technological advancements, North America continues to be a hub for mammalian-derived protein production and innovation.
- Europe:
- Europe, particularly countries like Germany, France, and the UK, shows strong growth potential in the mammalian-derived proteins market. The region has a strong biotechnology and pharmaceutical industry, alongside a well-established healthcare infrastructure.
- The growing adoption of mammalian cell cultures for producing monoclonal antibodies and recombinant proteins for therapeutic applications is contributing to the market expansion.
- Additionally, Europe is known for its regulatory standards and advancements in biologic drug production, which are facilitating market growth.
- Asia-Pacific:
- The Asia-Pacific (APAC) region is projected to exhibit the highest growth potential in the mammalian-derived proteins market over the coming years. Countries such as China, India, Japan, and South Korea are emerging as key players in this market due to rapid advancements in biotechnology, increasing investments in life sciences research, and a growing pharmaceutical industry.
- China is becoming a global leader in the production of biologics, with an increasing number of pharmaceutical and biotechnology companies investing in mammalian cell culture technologies.
- The region’s expanding healthcare infrastructure, increasing awareness of biologics, and rising demand for affordable therapeutics are major factors driving growth in the mammalian-derived proteins market.
- Latin America:
- Latin America is showing steady growth, driven by expanding pharmaceutical and biotechnology sectors in countries such as Brazil and Mexico.
- The demand for biologics and recombinant proteins, including vaccines and monoclonal antibodies, is driving market growth in the region.
- Increasing investments in healthcare, along with the growing focus on improving access to advanced medical treatments, are expected to positively influence the market.
- Middle East & Africa:
- Although this region currently holds a smaller market share, it shows strong potential for growth in the mammalian-derived proteins market due to rising healthcare investments and a growing pharmaceutical and biotechnology sector, particularly in countries like Saudi Arabia, the UAE, and South Africa.
- The increasing focus on improving healthcare services and access to biologic therapies is driving demand for mammalian-derived proteins.
Key Growth Drivers by Region:
- North America and Europe: High demand for biologic drugs, strong infrastructure, and R&D focus.
- Asia-Pacific: Growing manufacturing capabilities, increasing investments in biotechnology, and expanding healthcare access.
- Latin America and the Middle East: Emerging markets, rising healthcare demand, and a focus on improving local production of biologics and therapeutics.
Overall, Asia-Pacific is expected to witness the highest growth, while North America and Europe continue to dominate due to their established healthcare and pharmaceutical industries.
Key Players:
- Hoffmann-La Roche Ltd; Merck KGaA; Eli Lilly and Company; Lonza.; CUSABIO TECHNOLOGY LLC.; Prospec-Tany Technogene Ltd.; Randox Laboratories Ltd; Geno Technology Inc.; Kaneka Eurogentec S.A.; Batavia Biosciences.; Abnova Corporation; Cayman Chemical; SOSV LLC – IndieBio; Bioclone Inc
Key Segments Covered In The Mammalian Derived Proteins Industry Survey:
By Product:
- Monoclonal antibodies
- Clotting factors
- Hormones
- Cytokines
- Others
By Therapy Area:
- Cancer Therapies
- Myocardial Infarction
- Congestive Heart Failure
- Crohn’s Disease
- Fertility Treatments
- Haemophilia
- Others
By Application:
- Aptamer development
- Western blotting
- ELISA
- Protein Interaction
- Protein Structure
- Cell culture experiments
- Antibody profiling
- Improved altered functions
- Others
By End User:
- Biotechnology companies
- Research institutes
- Contract Research organizations
- Hospitals
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
